The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice

European Journal of Pharmacology

Volumn 659, Issue 1, 2011, Pages 53-60

  Chen, Xi ^a   Xu, Juan ^a   Zhang, Cheng ^a   Yu, Tao ^a   Wang, Hua ^a   Zhao, Mei ^a   Duan, Zi Hao ^a   Zhang, Ying ^a   Xu, Jian Ming ^a   Xu, De Xiang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Apoptosis; Hepatotoxicity; UDCA (Ursodeoxycholic acid)

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CASPASE 3; GLUTATHIONE; ISONIAZID; MALONALDEHYDE; PROTEIN BAX; PROTEIN BCL 2; RIFAMPICIN; URSODEOXYCHOLIC ACID; ANTIOXIDANT; TUBERCULOSTATIC AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; LIPID STORAGE; LIVER INJURY; LIVER LEVEL; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TOXIC HEPATITIS; ANIMAL; CELL PROTECTION; DRUG EFFECTS; DRUG INTERACTION; DRUG-INDUCED LIVER INJURY; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; ANTITUBERCULAR AGENTS; APOPTOSIS; CYTOPROTECTION; DRUG INTERACTIONS; DRUG-INDUCED LIVER INJURY; FEMALE; ISONIAZID; LIVER; MICE; OXIDATIVE STRESS; RIFAMPIN; URSODEOXYCHOLIC ACID;

EID: 79958837419     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.03.007     Document Type: Article

References (34)

1. Amaral, J.D., Castro, R.E., Solá, S., Steer, C.J., Rodrigues, C.M., 2007. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. J. Biol. Chem. 282, 34250-34259.
2. Attri, S., Rana, S.V., Vaiphei, K., Sidhi, C.P., Katyal, R., Goel, R.C., Nain, C.K., Singh, K., 2000. Isoniazid- and rifampicin-induced oxidative hepatic injury-protection by N-acetylcysteine. Hum. Exp. Toxicol. 19, 517-522.
3. Azzaroli, F., Mehal, W., Soroka, C.J., Wang, L., Lee, J., Crispe, N., Boyer, J.L., 2002. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis inmouse hepatocytes. Hepatology 36, 49-54. (Pubitemid 34700761)
4. Bhadauria, S., Singh, G., Sinha, N., Srivastava, S., 2007. Isoniazid induces oxidative stress, mitochondrial dysfunction and apoptosis in Hep G2 cells. Cell. Mol. Biol. 53, 102-114.
5. Botla, R., Spivey, J.R., Aguilar, H., Bronk, S.F., Gores, G.J., 1995. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J. Pharmacol. Exp. Ther. 272, 930-938.
6. Chowdhury, A., Santra, A., Kundu, S., Mukherjee, A., Pandit, A., Chaudhuri, S., Dhali, G.K., 2001. Induction of oxidative stress in antitubercular drug-induced hepatotoxicity. Indian J. Gastroenterol. 20, 97-100.
7. Chowdhury, A., Santra, A., Bhattacharjee, K., Ghatak, S., Saha, D.R., Dhali, G.K., 2006. Mitochondrial oxidative stress and permeability transition in Isoniazid and Rifampicin induced liver injury in mice. J. Hepatol. 45, 117-126. (Pubitemid 43850617)
8. Christiane, P.M., Peter, J.M., 2006. Hepatobiliary transporters and drug-induced cholestasis. Hepatology 44, 778-787.
9. El-Sherbiny, G.A., Taye, A., Abdel-Raheem, I.T., 2009. Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats. Ann. Hepatol. 8, 134-140.
10. Griffith, O.W., 1980. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212.
11. Hagey, L.R., Crombie, D.L., Espinosa, E., Carey, M.C., Igimi, H., Hofmann, A.F., 1993. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores. J. Lipid Res. 34, 1911-1917. (Pubitemid 23324966)
12. Hwang, S.J., Wu, J.C., Lee, C.N., Yen, F.S., Lu, C.L., Lin, T.P., Lee, S.D., 1997. A prospective clinical study of isoniazid - rifampicin - pyrazinamide-induced liver injury in an area endemic for hepatitis B. J. Gastroenterol. 12, 87-91.
13. Ishizaki, K., Iwaki, T., Kinoshita, S., Koyama, M., Fukunari, A., Tanaka, H., Tsurufuji, M., Sakata, K., Maeda, Y., Imada, T., Chiba, K., 2008. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production. Eur. J. Pharmacol. 578, 57-64.
14. Lazaridis, K.N., Gores, G.J., Lindor, K.D., 2001. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J. Hepatol. 35, 134-146. (Pubitemid 32646237)
15. Ljubuncic, P., Tanne, Z., Bomzon, A., 2000. Ursodeoxycholic acid suppresses extent of lipid peroxidation in diseased liver in experimental cholestatic liver disease. Dig. Dis. Sci. 45, 1921-1928.
16. Mitsuyoshi, H., Nakashima, T., Sumida, Y., Yoh, T., Nakajima, Y., Ishikawa, H., Inaba, K., Sakamoto, Y., Okanoue, T., Kashima, K., 1999. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem. Biophys. Res. Commun. 263, 537-542.
17. Oberley, T.D., Swanlund, J.M., Zhang, H.J., Kregel, K.C., 2008. Aging results in increased autophagy of mitochondria and protein nitration in rat hepatocytes following heat stress. J. Histochem. Cytochem. 6, 615-627.
18. Ohkawa, H., Ohishi, N., Yagi, K., 1979. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 44, 276-278.
19. Okada, K., Shoda, J., Taguchi, K., Maher, J.M., Ishizaki, K., Inoue, Y., Ohtsuki, M., Goto, N., Takeda, K., Utsunomiya, H., Oda, K., Warabi, E., Ishii, T., Osaka, K., Hyodo, I., Yamamoto, M., 2008. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295, 735-747.
20. Paumgartner, G., Beuers, U., 2002. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 36, 525-531. (Pubitemid 34977162)
21. Perez, M.J., Macias, R.I.R., Duran, C., Monte, M.J., Gonzalez-Buitrago, J.M., Marin, J.J.G., 2005. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid. J. Hepatol. 43, 324-332.
22. Poupon, R.E., Lindor, K.D., Cauch-Dudek, K., Dickson, E.R., Poupon, R., Heathcote, E.J., 1997. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113, 884-890. (Pubitemid 27381148)
23. Preziosi, P., 2007. Isoniazid: metabolic aspects and toxicological correlates. Curr. Drug Metab. 8, 839-851.
24. Rodrigues, C.M., Fan, G., Ma, X., Kren, B.T., Steer, C.J., 1998. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101, 2790-2799.
25. Rodrigues, C.M., Ma, X., Linehan-Stieers, C., Fan, G., Kren, B.T., Steer, C.J., 1999. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 6, 842-854. (Pubitemid 29488082)
26. Sano, K., Tomioka, H., Sato, K., Sano, C., Kawauchi, H., Cai, S., Shimizu, T., 2004. Interaction of antimycobacterial drugs with the anti-mycobacterium avium complex effects of antimicrobial effectors, reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids produced by macrophages. Antimicrob. Agents Chemother. 48, 2132-2139.
27. Schoemaker, M.H., Conde de la Rosa, L., Buist-Homan, M., Vrenken, T.E., Havinga, R., Poelstra, K., Haisma, H.J., Jansen, P.L., Moshage, H., 2004. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39, 1563-1573. (Pubitemid 38702657)
28. Serviddio,G.,Pereda, J., Pallardo, F.V., Carretero, J., Borras,C.,Cutrin, J.,Vendemiale, G.,Poli,G., Vina, J., Sastre, J., 2004. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology 39, 711-720. (Pubitemid 38337650)
29. Sodhi, C.P., Rana, S.V., Mehta, S.K., Vaiphei, K., Attri, S., Thakur, S., Mehta, S., 1996. Study of oxidative stress in isoniazid-induced hepatic injury in young rats with and without protein-energy malnutrition. J. Biochem. Toxicol. 11, 139-146.
30. Sodhi, C.P., Rana, S.V., Mehta, S.K., Vaiphei, K., Attari, S., Mehta, S., 1997. Study of oxidative-stress in isoniazid - rifampicin induced hepatic injury in young rats. Drug Chem. Toxicol. 20, 255-269.
31. Steele, M.A., Burk, R.F., DesPrez, R.M., 1991. Toxic hepatitis with isoniazid and rifampicin. A meta-analysis. Chest 99, 465-471.
32. Tasdug, S.A., Kaiser, P., Sharma, S.C., Johri, R.K., 2007. Potentiation of isoniazid-induced liver toxicity by rifampicin in a combinational therapy of antitubercular drugs (rifampicin, isoniazid and pyrazinamide) in Wistar rats: a toxicity profile study. Hepatol. Res. 37, 845-853.
33. Uraz, S., Tahan, V., Aygun, C., Eren, F., Unluguzel, G., Yuksel, M., Senturk, O., Avsar, E., Haklar, G., Celikel, C., Hulagu, S., Tozun, N., 2008. Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity. Dig. Dis. Sci. 53, 1071-1077.
34. Yue, J., Peng, R.X., Yang, J., Kong, R., Liu, J., 2004. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Acta Pharmacol. Sin. 25, 699-704.